| Literature DB >> 31336740 |
Luz M Hernández-Maldonado1, Francisco J Blancas-Benítez1, Victor M Zamora-Gasga1, Alicia P Cárdenas-Castro1, Juscelino Tovar2, Sonia G Sáyago-Ayerdi3.
Abstract
Mango (Mangifera indica L.) is a tropical fruit which is considered to be a source of dietary fiber (DF) and phenolic compounds (PCs). In this study, high DF mango-based fruit bars were developed from whole mango (peel and pulp). The bars were evaluated for their nutritional composition, the bioaccesibility of PCs during gastrointestinal digestion, and the PCs metabolites profile after in vitro colonic fermentation. The amount of DF in a 30 g portion of mango bars was 9.5 g, i.e., 35% of the recommended daily intake. Phenolic acids such as gallic acid; cinnamic acids, such as ferulic, coumaric, and caffeic acids; flavonoids such as quercertin; and xanthones such as mangiferin and mangiferin gallate, were identified as the main PCs in the bars. The antioxidant capacity associated with the PCs profile, together with the high DF content are indicative of the potential functional features of these natural fruit bars. The bioaccesibility of PCs in the mango bar was 53.78%. During fermentation, the PCs were bioconverted mainly to hydroxyphenolic acids and the main short-chain fatty acid produced was acetic acid. The xanthone norathyriol was identified after 12 h of fermentation. This study on the digestion and colonic fermentation of mango-based bars using in vitro models provides hints of the potential physiological behavior of PCs associated with DF, which constitutes relevant information for further development of natural and health-promoting fruit-based bars.Entities:
Keywords: antioxidant capacity; bioaccessibility; fruit-based bars; in vitro digestion; mango; phenolic compounds
Year: 2019 PMID: 31336740 PMCID: PMC6682962 DOI: 10.3390/nu11071564
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1In vitro digestion of the mango bars. Step 1, gastric fraction (GASF) (pepsin); Step 2, intestinal fraction (IntF) (pancreatin and amylase); Step 3, centrifugation to separate supernatants and residues; Step 4, dialysis for 24–48 h; Step 5, non-bioaccessible PCs associated with soluble indigestible fraction (SIF); Step 6, non-bioaccessible PCs associated with insoluble indigestible fraction (IIF); and Step 7, colonic fermentation of the isolated indigestible fraction (IF) from mango bars.
Figure 2Mango-based bar prepared with peel and paste.
Nutritional composition, total soluble polyphenols (TSP), antioxidant capacity (AOX; ABTS, FRAP), and hydrolyzable polyphenols (HP) of mango-based bar. 1
| Nutritional Composition (g/100 g DW) | |
|---|---|
| Moisture | 8.33 ± 0.22 |
| Protein 2 | 1.69 ± 0.13 |
| Fat | 0.45 ± 0.01 |
| Ash | 2.95 ± 0.09 |
| TSC 3 | 51.98 ± 0.61 |
| TDF 4 | 31.85 ± 0.22 |
| SDF | 14.38 ± 0.15 |
| IDF | 16.94 ± 0.11 |
| TSP (g GAE/100 g sample DW) | 14.35 ± 0.70 |
| AOX (μmol TE/g sample DW) | |
| ABTS | 314.00 ± 1.43 |
| FRAP | 201.03 ± 20.1 |
| HP (g GAE/g sample DW) | 5.43 ± 0.26 |
1 Values represent mean ± standard deviation (n = 3), 2 N × 6.25 conversion factor, 3 TSC: total soluble carbohydrates, and 4 TDF: total dietary fiber as the sum of soluble dietary fiber (SDF) + insoluble dietary fiber (IDF).
Total soluble polyphenols profile in mango-based bar. 1
| Compound | RT (min) | M/Z (-) | Relative Abundance (%) 2 |
|---|---|---|---|
|
| |||
| Gallic acid | 3.74 | 169 | 0.46 |
|
| |||
| Coumaric acid | 3.839 | 168 | 2.10 |
| Ferulic acid | 4.043 | 193 | 9.72 |
| Caffeic acid | 4.153 | 179 | 0.61 |
|
| |||
| Quercetin | 3.914 | 301 | 2.71 |
|
| |||
| Mangiferin gallate | 4.287 | 573 | 3.27 |
| Mangiferin | 14.269 | 421 | 81.13 |
1 Values represent mean ± standard deviation (n = 3) and 2 relative abundance (%) calculated from arbitrary units from MS area.
Release of total soluble polyphenols (TSP), phenolic compounds (PCs) profile, and antioxidant capacity (AOX; ABTS, FRAP) in gastric fraction (GasF), intestinal fraction (IntF), and bioaccessibility (%) upon in vitro digestion of mango-based bar.
| g/100 g DW | |
|---|---|
|
| |
| TSP (g GAE/100 g DW) | 16.79 ± 0.03 a |
|
| |
| Gallic acid | 1.90 |
| 2-Hydroxycinnamic acid | 0.30 |
| Ferulic acid | 2.33 |
| Caffeic acid | 0.10 |
| Mangiferin | 8.67 |
| Kaempferol | 84.30 |
| p-Coumaric acid | 1.82 |
| Quercetin | 0.58 |
|
| |
| ABTS | 470.77 ± 0.02 c |
| FRAP | 22.73 ± 0.08 d |
|
| |
| TSP (g GAE/100 g DW) | 15.32 ± 0.19 b |
|
| |
| Gallic acid | 5.57 |
| 2-Hydroxycinnamic acid | 21.72 |
| Ferulic acid | 1.08 |
| Caffeic acid | 0.65 |
| Mangiferin | 44.16 |
| Kaempferol | 18.59 |
| p-Coumaric acid | 5.18 |
| Quercetin | 3.05 |
|
| |
| ABTS | 469.98 ± 0.01 c |
| FRAP | 14.54 ± 0.08 d |
|
| 53.78 ± 0.03 |
1 Relative abundance (%) calculated from arbitrary units from MS area, values represent the mean ± standard deviation (n = 3), different letters in the same column indicate a significant difference in each assay (p < 0.05), ND = not detected. , PC-IntF = the PCs released in the intestinal fraction, PC-IIF = the PCs associated with insoluble indigestible fraction, and PC-SIF = the PCs associated with soluble indigestible fraction.
Total, soluble, and insoluble indigestible fraction (TIF, SIF, and IIF) content, total soluble polyphenols (TSP), antioxidant capacity (AOX; ABTS, FRAP), phenolic compounds (PCs) profile, and non-bioaccessible content upon in vitro digestion of the mango-based bar.
|
| 38.72 ± 2.18 |
|
| 24.44 ± 0.85 |
| TSP (g GAE/100 g DW) | 41.86 ± 0.10 a |
|
| |
| Gallic acid | 9.51 |
| 2-Hydroxycinnamic acid | 19.98 |
| Ferulic acid | ND |
| Caffeic acid | 0.32 |
| Mangiferin | 16.78 |
| Kaempferol | 50.73 |
| p-Coumaric acid | 1.25 |
| Quercetin | 1.43 |
|
| |
| ABTS | 117.50 ± 0.02 a |
| FRAP | 6.15 ± 0.06 a |
|
| 14.28 ± 1.35 |
| TSP (g GAE/100 g DW) | 60.98 ± 0.14 b |
|
| |
| Gallic acid | ND |
| 2-Hydroxycinnamic acid | ND |
| Ferulic acid | 5.65 |
| Caffeic acid | ND |
| Mangiferin | 4.86 |
| Kaempferol | 85.34 |
| p-Coumaric acid | 1.61 |
| Quercetin | 2.54 |
|
| |
| ABTS | 118.21 ± 0.01 b |
| FRAP | 11.87 ± 0.01 b |
|
| 46.22 ± 0.03 |
1 Relative abundance calculated from arbitrary units from MS area, values represent the mean ± standard deviation (n = 3), different letters in the same column indicate significant differences on each assay, ND = not detectable.
Figure 3pH changes during in vitro colonic fermentation of negative control (■), raffinose (▲), and indigestible fraction of (●) mango bar. Values are means ± Standard Error of the Mean (SEM) (n = 3). Different letters show significant difference between each fermentation time per sample using two-way ANOVA/Fisher’s LSD test, p < 0.05.
Concentration of short chain fatty acids (SCFA) produced during the colonic fermentation of total indigestible fraction of mango-based bar (TIF-MB) and positive control (raffinose). 1
| SCFA | Time (h) | Raffinose mmol/L | TIF-MB mmol/L |
|---|---|---|---|
| Acetic acid | 6 | 62.60 ± 4.31 a,D | 19.75 ± 4.78 a,B |
| 12 | 193.84 ± 30.74 a,C | 25.68 ± 1.45 b,B | |
| 24 | 465.54 ± 48.85 a,B | 146.62 ± 52.87 b,A | |
| 48 | 1295.40 ± 170.86 a,A | 144.82 ± 25.61 b,A | |
| Propionic acid | 6 | ND a,D | ND a,C |
| 12 | 3.21 ± 0.84 a,C | 2.38 ± 0.89 a,B | |
| 24 | 27.05 ± 4.82 a,B | 11.10 ± 2.71 b,A | |
| 48 | 52.31 ± 1.05 a,A | 5.13 ± 1.50 b,A,B | |
| Butyric acid | 6 | 0.12 ± 0.00 a,C | ND a,D |
| 12 | 1.62 ± 0.24 a,B | 0.50 ± 0.03 b,C | |
| 24 | 4.38 ± 0.70 a,A | 3.04 ± 0.06 a,B | |
| 48 | 5.24 ± 1.94 a,A | 9.71 ± 1.32 a,A |
1 Values have been reported as mean ± standard error of three replicates. Different lowercase letters indicate significant differences in rows among substrates for a time and different capital letters indicate significant differences in columns among time for a substrate using two-way ANOVA/Fisher’s LSD test, p < 0.05. ND = not detectable.
Phenolic compounds identified on in vitro colonic fermentation of indigestible fraction of mango bars by HPLC-DAD-MS.
| Compound | RT (min) | m/z (-) | Relative Abundance 1 | |||
|---|---|---|---|---|---|---|
| 6 h | 12 h | 24 h | 48 h | |||
|
| ||||||
| Gallic acid | 6.33 | 169 | 77.7 a | 18.1 b | 3.0 c | 1.2 c |
|
| ||||||
| Ferulic acid | 3.91 | 193 | 93.3 a | 6.7 b | ND | ND |
| Coumaric acid | 4.33 | 163 | ND | 100.0 | ND | ND |
| Chlorogenic acid | 4.38 | 353 | 79.4 a | 20.6 b | ND | ND |
|
| ||||||
| Quercetin | 19.64 | 301 | 100.0 | ND | ND | ND |
| Catechin | 4.59 | 289 | 61.7 a | 16.3 b | 22.0 b | ND |
| Galocatechin | 3.94 | 305 | 100.0 a | ND | ND | ND |
| Galocatechin galate | 12.41 | 457 | 93.4 a | 6.6 b | ND | ND |
|
| ||||||
| Mangiferin | 14.39 | 421 | 68.5 a | 31.5 b | ND | ND |
| Norathyriol | 11.34 | 259 | 87.7 a | 12.3 b | ND | ND |
|
| ||||||
| 3-(3,4)-Dihydroxyphenylpropionic acid | 5.25 | 181 | ND | 100.0 | ND | ND |
| 3-(4-Hydroxyphenyl)propionic acid | 4.01 | 165 | 100.0 | ND | ND | ND |
| 3,4-Dihydroxyphenylacetic acid | 10.81 | 167 | ND | 43.2 a | 36.3 a | 20.5 a |
| 4-Hydroxyphenylacetic acid | 12.23 | 151 | 27.5 a | 8.8 b | 33.8 a | 29.9 a |
| 4-Hydroxybenzoic acid | 11.29 | 137 | 24.5 a | 38.4 a | 37.1 a | ND |
1 Relative abundance (%) calculated from arbitrary units from MS area, different lowercase letters in the same row indicates significant differences (p < 0.05). ND = not detectable.
Figure 4(a) Biotransformation of (■) gallocatechin to (▲) catechin, (●) 3-(4-hydroxyphenyl) propionic acid and (◆) 4-hydroxyphenylacetic acid during 48 h of colonic fermentation. (b) Biotransformation of (▲) quercetin to (●) 3-(3,4)-dihydroxyphenylpropionic acid, (■) 3,4-dyhydroxyphenylacetic acid and (◆) 4-hydroxyphenylacetic acid, during 48 h of colonic fermentation.